OrthoPediatrics (NASDAQ:KIDS) Stock Price Down 4.2% – Time to Sell?

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) were down 4.2% during mid-day trading on Tuesday . The company traded as low as $23.39 and last traded at $23.96. Approximately 60,941 shares traded hands during trading, a decline of 78% from the average daily volume of 275,512 shares. The stock had previously closed at $25.00.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Needham & Company LLC restated a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Tuesday. Truist Financial cut their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th.

OrthoPediatrics Trading Up 1.7 %

The firm has a fifty day moving average of $23.97 and a 200-day moving average of $27.37. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock has a market capitalization of $642.45 million, a price-to-earnings ratio of -21.57 and a beta of 1.14.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP raised its stake in shares of OrthoPediatrics by 16.2% during the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after purchasing an additional 122,846 shares during the period. State Street Corp increased its stake in OrthoPediatrics by 1.0% during the 3rd quarter. State Street Corp now owns 417,898 shares of the company’s stock worth $11,329,000 after buying an additional 4,236 shares during the period. Geode Capital Management LLC lifted its holdings in OrthoPediatrics by 2.1% in the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock worth $10,615,000 after buying an additional 7,972 shares in the last quarter. Portolan Capital Management LLC boosted its position in OrthoPediatrics by 66.2% in the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock valued at $8,353,000 after buying an additional 122,770 shares during the last quarter. Finally, Harbor Capital Advisors Inc. grew its stake in shares of OrthoPediatrics by 1.9% during the fourth quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company’s stock valued at $5,832,000 after acquiring an additional 4,728 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.